Top 40 arGEN-X investors
The most complete profiles first. Showing 40 of 41.
Alexander VosVerified
Venture Capital, Micro VC, Investor · Netherlands
SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnologyPortfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more
Verified email available
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Anastasia KarpovaVerified
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Florian LudwigVerified
Micro VC · Netherlands
Health CareWearablesSportsWellnessPortfolio: Intercell, Coley Pharmaceutical Group, TheraSolve, Salvia BioElectronics and 27 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Diede Brunen
Venture Capital, Private Equity Firm, Micro VC · Netherlands
SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnologyPortfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more
Contact details available
Drew Burdon
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Edward Van Wezel
Venture Capital, Micro VC, Investor · Netherlands
SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnologyPortfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more
Contact details available
Geert
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor · Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Joost Holthuis
Venture Capital, Micro VC, Investor · Netherlands
SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnologyPortfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more
Contact details available
Juliette Audet
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Martijn Kleijwegt
Venture Capital, Private Equity Firm, Investor · Netherlands
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Max Klement
Venture Capital, Micro VC, Investor · United Kingdom
SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnologyPortfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more
Contact details available
Rob de Ree
Venture Capital, Micro VC, Investor · Netherlands
SeedPre-SeedHealth CareLife ScienceManufacturingBiotechnologyPortfolio: Confo Therapeutics, Lanthio Pharma, Scenic Biotech, Cristal Therapeutics and 13 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Rudy Dekeyser
Venture Capital, Private Equity Firm, Investor · Belgium
Series BHealth CareHospitalsLife ScienceMobilePortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Vincent Brichard
Private Equity Firm, Investor · Netherlands
SeedHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Asiya Giniatullina
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Avi Corcos
Venture Capital · France
Health CareE-commerceCybersecurityHR TechPortfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more
Contact details available
Bonnie van Wilgenburg
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Marc
Venture Capital · France
Health CareE-commerceCybersecurityHR TechPortfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more
Contact details available
Merijn Klaassen
Private Equity Firm · Netherlands
Health CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Michel Briejer
Micro VC · Netherlands
Health CareWearablesSportsWellnessPortfolio: Intercell, Coley Pharmaceutical Group, TheraSolve, Salvia BioElectronics and 27 more
Contact details available
Renaud POULARD
Venture Capital, Private Equity Firm · France
Health CareE-commerceCybersecurityDeepTechPortfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more
Contact details available
Sander van Deventer
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Serge Savasta
Venture Capital, Private Equity Firm · France
Health CareE-commerceCybersecurityDeepTechPortfolio: VSORA, eFrontech, viavoo, Tiller Systems and 76 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
See all 41 arGEN-X investors
Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many arGEN-X investors are on Angel Roster?
Angel Roster lists 41 arGEN-X investors. 9 of them (22%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (37), Private Equity Firms (23) and Investment Partner Investors (9). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do arGEN-X investors invest in?
Among those that list a stage, the most common are Seed (16), Pre-Seed (6) and Series B (3).
Where are arGEN-X investors based?
Most are based in the Netherlands (22), the United States (9) and France (5).
Which companies have arGEN-X investors backed?
The most-backed portfolio companies among them are Dyne Therapeutics (23), Escalier Biosciences (20), Dezima Pharma (20), NorthSea Therapeutics (20) and Azafaros (20).
How do I contact arGEN-X investors?
Create a free Angel Roster account to search and filter all 41, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.